The following IPOs are expected to price this week:
Aratana Therapeutics (PETX), which is developing medications for cats and dogs based on therapies for human, plans to raise $51 million by offering 4.3 million shares at a price range of $11.00 to $13.00. At the midpoint of the proposed range, Aratana Therapeutics would command a market value of $223 million. Aratana Therapeutics, which was founded in 2010, booked $0 million in sales over the last 12 months. The Kansas City, KS-based company plans to list on the NASDAQ under the symbol PETX. Stifel and Lazard Capital Markets are the joint bookrunners on the deal.
Coty (COTY), a fragrance and cosmetics company with several globally recognized brands, plans to raise $1,000 million by offering 57.1 million shares at a price range of $16.50 to $18.50. At the midpoint of the proposed range, Coty would command a market value of $7.0 billion. Coty, which was founded in 1904, booked $4.6 billion in sales over the last 12 months. The New York, NY-based company plans to list on the NYSE under the symbol COTY. BofA Merrill Lynch, J.P. Morgan, Morgan Stanley and Barclays are the joint bookrunners on the deal.
Gigamon (GIMO), which provides data traffic management software-based appliances, plans to raise $128 million by offering 6.8 million shares at a price range of $18.00 to $20.00. At the midpoint of the proposed range, Gigamon would command a market value of $612 million. Gigamon, which was founded in 2004, booked $106 million in sales over the last 12 months. The Milpitas, CA-based company plans to list on the NYSE under the symbol GIMO. Goldman Sachs, BofA Merrill Lynch, Credit Suisse and Barclays are the joint bookrunners on the deal.
Renaissance Capital will have Pre-IPO Research available on each of these upcoming IPOs prior to its pricing.
Last week, there were 3 IPO pricings. Textura (TXTR), which provides on-demand project management software for the construction industry, was the week's winner, ending up 39% from its IPO price.
